Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
about
Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhageTranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.Intraoperative tranexamic acid is associated with postoperative stroke in patients undergoing cardiac surgery.A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial BleeSuccessful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature.An assessment of randomized controlled trials (RCTs) for non-communicable diseases (NCDs): more and higher quality research is required in less developed countries.The critical care management of poor-grade subarachnoid haemorrhageDiscovery of a ROCK inhibitor, FPND, which prevents cerebral hemorrhage through maintaining vascular integrity by interference with VE-cadherin.Statistical analysis plan for the 'Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage' (TICH-2) trial.The effectiveness and safety of antifibrinolytics in patients with acute intracranial haemorrhage: statistical analysis plan for an individual patient data meta-analysis.Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial.Antifibrinolytic Therapy and Perioperative Considerations.Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage.Aneurysmal Subarachnoid Hemorrhage.
P2860
Q27003355-FA251920-288B-4EB1-BA96-198EFFACFE9FQ33676496-A177EE31-A287-4BAC-83DF-18EA740CE4EBQ33731928-BDF54CCB-7025-4B7B-ACE2-A38E25A1176AQ33909468-6BA12412-3BB2-4B73-B76A-6D553FBC3658Q35071654-02BE664F-0B4E-4AA4-B2F0-2472245E86F6Q36273547-602CE318-9A62-4471-8D60-2B207845F517Q36493587-39F70777-0915-43D5-B237-0D5D3BB594C4Q41464226-AD05BAC3-6065-4BFF-B48C-BEA72D5EE1AFQ48374871-0581CB83-B72E-459C-BB45-F87E8C05229CQ50054586-61E3B34C-1AEE-461B-9B5A-CA32124157ADQ50069361-5F5B11D2-9C7B-47D1-B7A1-47039298C7CFQ50099821-06B33F6E-5C3E-4C52-9582-5F44F2DD5F1EQ53079755-0ED4D6E8-9E93-4EA3-927F-7D08C759AAB3Q53083421-DFA26C2E-938C-4A6A-A328-A67873A5EB3B
P2860
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@ast
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@en
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@en-gb
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@nl
type
label
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@ast
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@en
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@en-gb
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@nl
prefLabel
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@ast
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@en
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@en-gb
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@nl
P2093
P2860
P1476
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
@en
P2093
Gabriel JE Rinkel
Jan van Gijn
Marinus Vermeulen
Menno R Germans
Merih I Baharoglu
Yvo BWEM Roos
P2860
P356
10.1002/14651858.CD001245.PUB2
P50
P577
2013-08-30T00:00:00Z